Nova Patents
ATE528016T1

Virus-like particles as vaccines for paramyxovirus

Abstract

The invention provides expression vectors and virus-like particles (VLPs) containing Newcastle Disease Virus Sequences in combination with sequences encoding proteins of interest. The vectors are useful in, for example, generating virus-like particles (VLPs) that contain proteins of interest. In one embodiment, the expressed VLPs elicit an immune response by an animal host against the protein. The invention's VLPs are useful as, for example, vaccines.

Term

Term ended

Projected expiry passed 3 August 2026, 0.1 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

38 members in 14 offices

This recordMember, by publication datePriority claim4 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
70612605United States of AmericaP
49788806United States of AmericaA
2006030319United States of AmericaW

Members38

Family members, oldest first
DocumentOfficeKind
AU2006278588A1AustraliaA1
CA2617508A1CanadaA1
WO2007019247A2World Intellectual Property Organization (WIPO)A2
US2007178120A1United States of AmericaA1
WO2007019247A3World Intellectual Property Organization (WIPO)A3
EP1917033A2European Patent Office (EPO)A2
IL189313A0IsraelA0
KR20080072627ARepublic of KoreaA
CN101282744AChinaA
JP2009502204AJapanA
US2009068221A1United States of AmericaA1
HK1125051AHong Kong, ChinaA
HK1125051A1Hong Kong, ChinaA1
CA2715237A1CanadaA1
WO2009105152A2World Intellectual Property Organization (WIPO)A2
EP1917033A4European Patent Office (EPO)A4
RU2008106445ARussian FederationA
US2009263420A1United States of AmericaA1
WO2009105152A3World Intellectual Property Organization (WIPO)A3
EP2242510A2European Patent Office (EPO)A2
BRPI0614702A2BrazilA2
US2011097355A1United States of AmericaA1
US7951384B2United States of AmericaB2
EP1917033B1European Patent Office (EPO)B1
AT528016TAustriaT
ATE528016T1This recordAustriaT1
NZ565961ANew ZealandA
CN101282744BChinaB
KR101120784B1Republic of KoreaB1
EP2242510A4European Patent Office (EPO)A4
JP2013176375AJapanA
JP5342234B2JapanB2
CA2617508CCanadaC
US8974797B2United States of AmericaB2
IL189313AIsraelA
US9216212B2United States of AmericaB2
US9399059B2United States of AmericaB2
EP2242510B1European Patent Office (EPO)B1